Eventide Asset Management, LLC Satsuma Pharmaceuticals, Inc. Transaction History

Eventide Asset Management, LLC

  • $5.68 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$3.85 - $28.47 $3.79 Million - $28 Million
-983,382 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$14.53 - $30.69 $8.11 Million - $17.1 Million
558,382 Added 131.38%
983,382 $20.6 Million
Q3 2019

Nov 21, 2019
BUY
$14.98 - $16.9 $6.37 Million - $7.18 Million
425,000 New
425,000 $6.38 Million

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email